Yanbing Li

7.5k total citations
266 papers, 4.4k citations indexed

About

Yanbing Li is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Yanbing Li has authored 266 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Endocrinology, Diabetes and Metabolism, 100 papers in Molecular Biology and 64 papers in Surgery. Recurrent topics in Yanbing Li's work include Diabetes Treatment and Management (32 papers), Diabetes Management and Research (32 papers) and Metabolism, Diabetes, and Cancer (30 papers). Yanbing Li is often cited by papers focused on Diabetes Treatment and Management (32 papers), Diabetes Management and Research (32 papers) and Metabolism, Diabetes, and Cancer (30 papers). Yanbing Li collaborates with scholars based in China, United States and Australia. Yanbing Li's co-authors include Haipeng Xiao, Zhimin Huang, Xiaopei Cao, Hongyu Guan, Shuang Yu, Zhihong Liao, Liehua Liu, Hai Li, Shubin Hong and Hongyu Guan and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yanbing Li

250 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanbing Li China 36 1.8k 1.5k 823 816 394 266 4.4k
Li Yan China 34 1.3k 0.7× 1.4k 0.9× 391 0.5× 612 0.8× 187 0.5× 269 4.8k
Jung‐Min Koh South Korea 37 1.7k 1.0× 998 0.6× 427 0.5× 902 1.1× 277 0.7× 186 4.7k
I. Byrjalsen Denmark 42 1.7k 1.0× 870 0.6× 587 0.7× 823 1.0× 604 1.5× 143 5.6k
Beom‐Jun Kim South Korea 34 2.4k 1.4× 617 0.4× 814 1.0× 571 0.7× 326 0.8× 185 4.8k
Sang Soo Kim South Korea 32 1.1k 0.6× 1.0k 0.7× 297 0.4× 543 0.7× 237 0.6× 238 3.8k
Liming Chen China 36 1.5k 0.9× 1.1k 0.7× 290 0.4× 855 1.0× 194 0.5× 175 4.4k
Yuzhen Zhang China 37 3.0k 1.7× 591 0.4× 1.0k 1.3× 1.2k 1.5× 311 0.8× 146 5.6k
Begoña López Spain 52 2.0k 1.1× 823 0.5× 679 0.8× 1.5k 1.9× 194 0.5× 150 9.1k
Roger Foo Singapore 39 3.0k 1.7× 427 0.3× 1.1k 1.3× 655 0.8× 375 1.0× 195 5.3k
Naoharu Iwai Japan 48 3.7k 2.1× 1.9k 1.2× 1.6k 2.0× 616 0.8× 577 1.5× 126 7.1k

Countries citing papers authored by Yanbing Li

Since Specialization
Citations

This map shows the geographic impact of Yanbing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbing Li more than expected).

Fields of papers citing papers by Yanbing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanbing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbing Li. The network helps show where Yanbing Li may publish in the future.

Co-authorship network of co-authors of Yanbing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yanbing Li. A scholar is included among the top collaborators of Yanbing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanbing Li. Yanbing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liang, Weiwei, Yilin Zhang, Yan Guo, et al.. (2024). FLNA overexpression promotes papillary thyroid cancer aggression via the FAK/AKT signaling pathway. Endocrine Connections. 13(6). 1 indexed citations
3.
Zhao, Jiaxin, Yayuan Mei, Ang Li, et al.. (2024). Association between PM2.5 constituents and cardiometabolic risk factors: Exploring individual and combined effects, and mediating inflammation. Chemosphere. 359. 142251–142251. 1 indexed citations
4.
Gong, Yingying, Meilin Wei, Xiaopei Cao, et al.. (2024). Mbnl1-mediated alternative splicing of circMlxipl regulates Rbbp6-involved ChREBP turnover to inhibit lipotoxicity-induced β-cell damage. Molecular Medicine. 30(1). 229–229.
5.
6.
7.
Li, Kai, Jing Xu, Meiduo Zhao, et al.. (2023). Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis. Frontiers in Aging Neuroscience. 15. 1102762–1102762. 1 indexed citations
8.
Li, Yanbing, et al.. (2023). MBNL1-AS1 Promotes Hypoxia-Induced Myocardial Infarction via the miR-132-3p/RAB14/CAMTA1 Axis. Oxidative Medicine and Cellular Longevity. 2023. 1–12. 2 indexed citations
9.
Chen, Mengke, Ye Sang, Yulu Chen, et al.. (2023). Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways. Thyroid. 33(12). 1441–1454. 18 indexed citations
10.
Lai, Fenghua, et al.. (2023). Pancreatic-derived factor predicts remission of impaired glucose tolerance women with history of gestational diabetes. Diabetes Research and Clinical Practice. 204. 110892–110892. 3 indexed citations
11.
Cao, Xiaopei, et al.. (2023). Application of glycemic qualification rate based on fingerstick glucose monitoring in women with gestational diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine. 36(1). 2203797–2203797. 2 indexed citations
12.
Chen, Li, Shuang Yu, Xia Lin, et al.. (2022). Therapeutic role of Artemether in the prevention of hepatic steatosis through miR‐34a‐5p/PPARα pathway. Drug Development Research. 84(2). 156–171. 4 indexed citations
13.
Yu, Shuang, Changan Liu, Jie Li, et al.. (2022). Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer. Oncogene. 41(17). 2422–2430. 20 indexed citations
14.
Li, Ting, Yang Yang, Ling Wang, et al.. (2022). Injectable composite hydrogels encapsulating gelatin methacryloyl/chitosan microspheres as ARPE-19 cell transplantation carriers. Biomaterials Science. 11(1). 278–287. 16 indexed citations
15.
Lin, Chenhong, Xiaoying He, Xueying Chen, et al.. (2022). miR-1275 Inhibits Human Omental Adipose-Derived Stem Cells Differentiation Toward the Beige Phenotype via PRDM16. Stem Cells and Development. 31(23-24). 799–809. 2 indexed citations
16.
Xie, Yang, et al.. (2021). Metformin protects against insulin resistance induced by high uric acid in cardiomyocytes via AMPK signalling pathways in vitro and in vivo. Journal of Cellular and Molecular Medicine. 25(14). 6733–6745. 20 indexed citations
17.
Li, Hai, Juan Liu, Liehua Liu, et al.. (2019). The Association between a 24-Hour Blood Pressure Pattern and Circadian Change in Plasma Aldosterone Concentration for Patients with Aldosterone-Producing Adenoma. International Journal of Endocrinology. 2019. 1–7. 3 indexed citations
18.
Liu, Juan, Jing Zheng, Weijian Ke, et al.. (2017). Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients. Journal of Diabetes Investigation. 9(4). 952–958. 23 indexed citations
20.
Li, Ying, Shuiqing Lai, Juan Liu, et al.. (2016). Ectopic Fat Deposition on Insulin Sensitivity: Correlation of Hepatocellular Lipid Content andMValue. Journal of Diabetes Research. 2016. 1–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026